Seres Therapeutics (MCRB) has released an update.
The Board of Directors of Seres Therapeutics, Inc. has scheduled the Company’s 2024 annual meeting of stockholders for April 4, 2024, with records at the close on February 12, 2024, being eligible to vote. The meeting will be conducted virtually with full details to be included in the proxy statement filed with the SEC. Stockholders must submit any business proposals or director nominations by February 9, 2024, in accordance with the Company’s Amended and Restated Bylaws and adhere to universal proxy rules for director nominee solicitations.
For further insights into MCRB stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
